[HTML][HTML] DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
A Chashchina, M Märklin, C Hinterleitner, HR Salih… - Scientific reports, 2021 - nature.com
DNAM-1 is reportedly expressed on cytotoxic T and NK cells and, upon interaction with its
ligands CD112 and CD155, plays an important role in tumor immunosurveillance. It has also …
ligands CD112 and CD155, plays an important role in tumor immunosurveillance. It has also …
[PDF][PDF] Clinical courses of two pediatric patients with acute megakaryoblastic leukemia harboring the CBFA2T3-GLIS2 fusion gene
M Ishibashi, T Yokosuka… - Turkish Journal of …, 2016 - jag.journalagent.com
Acute megakaryoblastic leukemia (AMKL) in children without Down syndrome (DS) has an
extremely poor outcome with 3-year survival of less than 40%, whereas AMKL in children …
extremely poor outcome with 3-year survival of less than 40%, whereas AMKL in children …
CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, M Awal Issah, T Liu… - Journal of …, 2020 - journals.sagepub.com
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
[HTML][HTML] Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia
Objective: Chronic lymphocytic leukemia (CLL) is a disease of nonproliferating and mature-
appearing B lymphocytes. Insulin-like growth factor-1 (IGF-1) is a small peptide hormone …
appearing B lymphocytes. Insulin-like growth factor-1 (IGF-1) is a small peptide hormone …